| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 04/03/2002 | EP1192189A2 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 04/03/2002 | EP1192135A2 Serine protease inhibitors |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP1192127A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
| 04/03/2002 | EP0898567B1 N-aminoalkyl-1-biphenylenyl-2-carboxamides; dopamine receptor subtype specific ligands |
| 04/03/2002 | EP0874645B1 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics |
| 04/03/2002 | CN1343219A Substituted phenethylamine derivatives |
| 04/03/2002 | CN1343197A Biphenyl derivatives as antagonists of neurokinine-1 receptor |
| 04/03/2002 | CN1342649A Bipiperazine derivatives with calcium ion antagon action |
| 04/02/2002 | US6365741 Reacting (i) a diisopropanolamine mixture or (ii) 1,2-diaminopropane with ammonia and hydrogen in the presence of a hydrogenation catalyst. |
| 03/28/2002 | WO2002024675A1 Process for manufacturing simvastatin and the novel intermediates |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024635A2 Aminoalcohol derivatives |
| 03/28/2002 | WO2002009651A3 Fatty acid synthase inhibitors |
| 03/28/2002 | WO2001089493A3 Compositions containing a benzamide disulfide derivative for treating allergic diseases |
| 03/28/2002 | WO2001064676A3 INHIBITORS OF p38-α KINASE |
| 03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
| 03/28/2002 | US20020037931 Treating mood disorders, Parkinson's disease, disorders of the gastrointestinal system, edema formation states and hypertension; for example, 6,7-dihydroxy-8-nitro-3,4-dihydro-2H-naphthalen-1-one |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | US20020037892 Bis-arylsulfones |
| 03/28/2002 | DE10040858A1 Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with polar radicals, process for their preparation and their use |
| 03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
| 03/27/2002 | EP1191020A2 Material for organic electroluminescence device and use thereof |
| 03/27/2002 | EP1190710A1 Preventive or therapeutic drugs for diabetes |
| 03/27/2002 | EP1189887A2 Process for preparing 10,11-methanobenzosuberane derivatives |
| 03/27/2002 | EP1189882A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor |
| 03/27/2002 | EP1189879A1 INHIBITORS OF FACTOR Xa |
| 03/27/2002 | EP1189875A2 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP0832079B1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 03/27/2002 | EP0782574B1 Bicyclic carboxamides as 5-ht1a receptors ligands |
| 03/27/2002 | CN1342153A Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in production of medicaments |
| 03/27/2002 | CN1342152A N-substituted imide derivatives with serotonergic activity |
| 03/27/2002 | CN1342137A N2 phenylamidine derivatives |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/26/2002 | US6362373 Chiral amino alcohols and process for preparation of same |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362369 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides |
| 03/26/2002 | US6362357 Use a catalyst system comprising nickel palladium or platinum and imidazoline-2-ylidene or imidazolidine-2-ylidene in stille coupling reactions |
| 03/26/2002 | US6362344 Reacting an aldehyde with organozinc compound in presence of catalytic erythro-b-amino alcohol |
| 03/26/2002 | US6362334 Phthalamide compounds |
| 03/26/2002 | US6362333 Method for simultaneously producing a cyclic lactam and a cyclic amine |
| 03/26/2002 | US6362332 Coproduction of a cyclic lactam and a cyclic amine |
| 03/26/2002 | US6362230 Alzheimer's disease |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/26/2002 | US6362200 Antitumor dibenzofluorene derivatives |
| 03/26/2002 | US6362183 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/26/2002 | US6362174 Analgesics, antiischemic agents, antieoileptic agents |
| 03/26/2002 | CA2032498C Novel 8-substituted-2-aminotetralines |
| 03/21/2002 | WO2002022694A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 03/21/2002 | WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/21/2002 | WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs |
| 03/21/2002 | WO2002022551A1 Derivatives of naphthalene with comt inhibiting activity |
| 03/21/2002 | WO2002022550A2 Chiral amino alcohols and process for preparation of same |
| 03/21/2002 | WO2001070672A3 Compounds and methods to treat alzheimer's disease |
| 03/21/2002 | WO2001034587A3 Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine |
| 03/21/2002 | WO2001034135A3 Oncolytic combinations for the treatment of cancer |
| 03/21/2002 | US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | CA2421054A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 03/21/2002 | CA2357467A1 Methods for treating osteoarthritis using an estrogen agonist/antagonist |
| 03/20/2002 | EP1189061A1 Multifunctional erythrocyte reagent containing carbamates and uses |
| 03/20/2002 | EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 03/20/2002 | EP1187815A1 4-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187814A2 5-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | EP0944587B1 Metalloproteinase inhibitors |
| 03/20/2002 | CN1341111A 1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands |
| 03/20/2002 | CN1341101A Phenyl-and pyridinyl derivatives |
| 03/20/2002 | CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/20/2002 | CN1341094A Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/20/2002 | CN1340503A Gas-solid catalytic process for synthesizing piperazine from ethanediamine and ethandiol |
| 03/19/2002 | US6359174 Reacting allyl reactant with acid chloride in presence of lewis acid catalyst |
| 03/19/2002 | US6359134 Sulfonamide derivatives, their production and use |
| 03/19/2002 | US6358960 For therapy of intravascular coagulation, coronary thrombosis, cerebral infarction, cerebral embolism, transient ischemic attack, cerebrovascular disorders, pulmonary vascular diseases, deep venous thrombosis, etc. |
| 03/19/2002 | US6358958 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/19/2002 | US6358942 Microbiocides and bactericides for treating grampositive, bacteroides, clostridium, mycobacterium, staphylococcus and streptococcus infections |
| 03/19/2002 | US6358515 Hydroquinone derivatives |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/19/2002 | CA2236673C (-)cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 03/19/2002 | CA2187114C Method of preparation of delmopinol using substituted isoxazolidines and isoxazolines |
| 03/14/2002 | WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | WO2002020501A2 Polyarylcarboxamides useful as lipid lowering agents |
| 03/14/2002 | WO2002020500A2 Materials and methods to potentiate cancer treatment |
| 03/14/2002 | WO2002020437A2 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them |
| 03/14/2002 | WO2002020016A1 AGENT FOR MODULATING EXCITATORY SYNAPTIC TRANSMISSION COMPRISING A COMPOUND HAVING ALPHA α7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATION PROPERTY |
| 03/14/2002 | WO2001070757A3 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 03/14/2002 | WO2001068612A3 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 03/14/2002 | US20020032348 Bactericides; reacting imine, carbamate, ester, amide and epoxide derivatives |
| 03/14/2002 | US20020032238 Lowering the plasma level of atherogenic lipoproteins; treating hyperlipidaemias, atherosclerosis or the clinical sequelae thereof, diabetes mellitus, adiposity or pancreatitis |
| 03/14/2002 | US20020032217 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 03/14/2002 | US20020032197 Methods and compositions for using moclobemide |
| 03/14/2002 | US20020032189 Amine compounds, their production and use |
| 03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/14/2002 | DE10041402A1 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren Novel compounds which inhibit factor Xa activity |
| 03/14/2002 | DE10040901A1 Neue Phenyl- und Phenylalkyl-substituierte Ethanolamine und Ethylendiamine New phenyl and phenylalkyl substituted ethanolamines and ethylenediamines |
| 03/14/2002 | CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |